What is the procedure for the Rapid Plasma Reagin (RPR) card test, including the antigen components, result reporting, sources of error, and limitations?

Rapid Plasma Reagin (RPR) Card Test: Procedure and Technical Considerations

Test Procedure

The RPR card test is a macroscopic, nontreponemal flocculation test performed on unheated serum or plasma using a modified VDRL antigen containing charcoal particles for visualization. 1

Basic Methodology

• Specimen preparation: The test can be performed on either serum or EDTA-treated plasma, though serum is the CDC-recognized standard 2

  • Plasma specimens should be tested within 18-24 hours of collection to maintain optimal agreement with serum results 2
  • After 18 hours at 25°C, qualitative agreement between plasma and serum is 99.0% 2

• Rotation methods: Two validated approaches exist 1

  • Mechanical rotator (standard method)
  • Hand rotation (practical alternative for resource-limited settings)
  • Agreement between methods is 98.8%, with hand rotation showing slightly lower sensitivity for minimal reactivity (titer = 1) 1

• Test execution: Antigen suspension containing cardiolipin, lecithin, cholesterol, and charcoal particles is mixed with patient specimen on a card and rotated 3

RPR Antigen Components

The RPR antigen consists of cardiolipin-lecithin-cholesterol antigen suspension with charcoal particles added for macroscopic visualization. 3

Key Antigen Characteristics

• Stability: RPR antigen demonstrates remarkable stability, showing no difference in reactivity after 3 months storage at room temperature (mean 21°C) or 30°C compared to 4°C storage 1

  • This stability is particularly advantageous for tropical and resource-limited settings 1

• Composition: Modified VDRL antigen with charcoal particles to enhance visualization of flocculation 3

Result Reporting

Results are reported both qualitatively (reactive/nonreactive) and quantitatively (titer) using serial dilutions. 4

Reporting Standards

• Qualitative results: Reactive or nonreactive based on visible flocculation 3

• Quantitative titers: Serial two-fold dilutions (e.g., 1:1:2,1:4,1:8,1:16,1:32,1:64, etc.) 5

  • Critical limitation: RPR and VDRL titers are NOT interchangeable and should not be used to manage the same patient 4
  • Only 29% of sera show concordant titers between RPR and VDRL 4

• Automated versus manual RPR: Automated systems often report titers 1-2 dilutions lower than manual RPR, particularly at high titers (≥1:16) 6

  • This systematic bias can affect clinical interpretation when transitioning between platforms 6

Sources of Error

Technical Errors

• Specimen handling issues 2

  • Plasma specimens stored >24 hours at 25°C show increased roughness (up to 16.7% with some tests) 2
  • Freeze-thaw cycles have minimal effect but should be minimized 6

• Interlaboratory variability: Significant discrepancies exist between laboratories 7

  • Up to 3-fold differences in titers between laboratories have been documented 7
  • This variability is clinically significant and can result in undertreatment or overtreatment 7

• Reading interpretation: Manual card tests are subject to reader interpretation variability 5

  • Automated systems reduce but do not eliminate this issue 5

Biological False Positives (BFP)

The RPR test is more specific than VDRL, giving fewer false positive results in selected BFP sera, though it can still produce BFP reactions in presumed normal sera. 8

• Common BFP causes (from clinical knowledge):

  • Pregnancy
  • Autoimmune diseases
  • Recent vaccinations
  • Acute viral infections
  • Malaria
  • HIV infection
  • Hepatitis C virus
  • Intravenous drug use

• Leprosy: RPR gives fewer BFP reactions than VDRL in lepromatous leprosy patients 8

Limitations of the Procedure

Sensitivity Limitations by Disease Stage

The RPR test has variable sensitivity depending on syphilis stage, with critical implications for diagnosis. 4

• Primary syphilis: 62-78% sensitive 4

  • Major pitfall: Nearly one-quarter of primary syphilis cases will be missed by RPR alone 4

• Secondary syphilis: 97-100% sensitive 4

  • Most reliable stage for RPR detection 4

• Late latent syphilis: Only 61-64% sensitive 4

  • Critical limitation: More than one-third of late latent cases will have nonreactive RPR 4

Comparative Performance Issues

• RPR versus VDRL: RPR is generally more sensitive and specific than VDRL across syphilis stages 4

  • However, titers between the two tests are not equivalent and cannot be used interchangeably 4

• Automated versus manual RPR: Quantitative concordance within 2-fold dilution ranges from 64-94% depending on the platform 5

  • AIX 1000 shows best quantitative agreement (94%) 5
  • BioPlex RPR shows lowest quantitative agreement (64%) 5

Clinical Scenario Limitations

• Ocular syphilis: 22% of ocular syphilis cases present with nonreactive RPR 9

  • These patients still benefit from antibiotic therapy despite nonreactive RPR 9
  • Reliance on RPR alone would miss these cases 9

• Neurosyphilis: No single laboratory test is perfectly sensitive and specific for neurosyphilis diagnosis 4

  • RPR should not be used as the sole diagnostic criterion 4

Practical Limitations

• Quantitative reproducibility: Point estimates for reproducibility range from 69-95% across different platforms 5

• Platform transition issues: Switching from manual to automated RPR requires clinician education about systematic titer differences 6

  • Failure to account for this can lead to inappropriate treatment decisions 6